Lab901
Loanhead
About Lab901
Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $24.2M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2009)
- Website: lab901.net
- Phone: +44 203-393-8531
Industries & Categories
Biotechnology, Developer Platform, Life Science
Canonical: https://fsome.com/organization/lab901-2665550 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.